nodes	percent_of_prediction	percent_of_DWPC	metapath
Antazoline—Trimethaphan—CHRNA3—schizophrenia	0.0357	0.215	CrCbGaD
Antazoline—HRH1—Amine ligand-binding receptors—TAAR6—schizophrenia	0.0285	0.0342	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—HTR6—schizophrenia	0.0283	0.034	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—CHRM1—schizophrenia	0.025	0.03	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—HTR6—schizophrenia	0.0238	0.0285	CbGpPWpGaD
Antazoline—HRH1—IL-4 Signaling Pathway—FES—schizophrenia	0.0229	0.0274	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—CHRM1—schizophrenia	0.021	0.0252	CbGpPWpGaD
Antazoline—Alverine—HTR1A—schizophrenia	0.018	0.108	CrCbGaD
Antazoline—HRH1—Monoamine GPCRs—HTR1B—schizophrenia	0.0178	0.0214	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—HTR1A—schizophrenia	0.0172	0.0206	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—HTR2C—schizophrenia	0.0166	0.0199	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—DRD1—schizophrenia	0.0166	0.0199	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—DRD3—schizophrenia	0.0161	0.0192	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—DRD4—schizophrenia	0.0156	0.0187	CbGpPWpGaD
Antazoline—Diphenidol—CHRM1—schizophrenia	0.0154	0.0927	CrCbGaD
Antazoline—HRH1—Amine ligand-binding receptors—HTR1B—schizophrenia	0.015	0.018	CbGpPWpGaD
Antazoline—Benzphetamine—SLC18A2—schizophrenia	0.0149	0.0898	CrCbGaD
Antazoline—HRH1—Monoamine GPCRs—HTR7—schizophrenia	0.0145	0.0174	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—DRD2—schizophrenia	0.0145	0.0174	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—HTR1A—schizophrenia	0.0144	0.0173	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—DRD1—schizophrenia	0.0139	0.0167	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—HTR2C—schizophrenia	0.0139	0.0167	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—DRD3—schizophrenia	0.0135	0.0162	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—DRD4—schizophrenia	0.0131	0.0157	CbGpPWpGaD
Antazoline—Bepridil—CACNA1C—schizophrenia	0.0128	0.0771	CrCbGaD
Antazoline—HRH1—Amine ligand-binding receptors—DRD2—schizophrenia	0.0122	0.0146	CbGpPWpGaD
Antazoline—HRH1—Amine ligand-binding receptors—HTR7—schizophrenia	0.0122	0.0146	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—DGKI—schizophrenia	0.0106	0.0127	CbGpPWpGaD
Antazoline—HRH1—Monoamine GPCRs—HTR2A—schizophrenia	0.0102	0.0122	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKI—schizophrenia	0.00948	0.0114	CbGpPWpGaD
Antazoline—Methadone—HTR3A—schizophrenia	0.00902	0.0543	CrCbGaD
Antazoline—HRH1—Amine ligand-binding receptors—HTR2A—schizophrenia	0.00855	0.0102	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—NTS—schizophrenia	0.00766	0.00919	CbGpPWpGaD
Antazoline—Modafinil—SLC6A3—schizophrenia	0.00713	0.0429	CrCbGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—schizophrenia	0.00685	0.00822	CbGpPWpGaD
Antazoline—Tripelennamine—CYP2D6—schizophrenia	0.0066	0.0398	CrCbGaD
Antazoline—Aprindine—CYP2D6—schizophrenia	0.00645	0.0389	CrCbGaD
Antazoline—HRH1—G alpha (q) signalling events—CHRM1—schizophrenia	0.00625	0.00749	CbGpPWpGaD
Antazoline—Benzphetamine—SLC6A3—schizophrenia	0.00618	0.0372	CrCbGaD
Antazoline—HRH1—G alpha (q) signalling events—GRM5—schizophrenia	0.00581	0.00696	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—TAAR6—schizophrenia	0.00561	0.00673	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM1—schizophrenia	0.00559	0.0067	CbGpPWpGaD
Antazoline—HRH1—IL-4 Signaling Pathway—FOS—schizophrenia	0.00548	0.00658	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—HTR6—schizophrenia	0.00547	0.00655	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—CCK—schizophrenia	0.00531	0.00637	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—schizophrenia	0.00519	0.00623	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—CCKAR—schizophrenia	0.00509	0.00611	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—NTS—schizophrenia	0.00507	0.00608	CbGpPWpGaD
Antazoline—Modafinil—CYP1A2—schizophrenia	0.00485	0.0292	CrCbGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—CHRM1—schizophrenia	0.00483	0.00579	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—schizophrenia	0.00475	0.0057	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR6—schizophrenia	0.00468	0.00562	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—schizophrenia	0.00455	0.00546	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—FZD3—schizophrenia	0.00454	0.00545	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—OXT—schizophrenia	0.00445	0.00534	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—TAAR6—schizophrenia	0.00427	0.00512	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—GRM2—schizophrenia	0.00427	0.00512	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—NPS—schizophrenia	0.00422	0.00506	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—HTR2C—schizophrenia	0.00414	0.00496	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM1—schizophrenia	0.00414	0.00496	CbGpPWpGaD
Antazoline—Bepridil—CYP2D6—schizophrenia	0.00399	0.024	CrCbGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—schizophrenia	0.00398	0.00477	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—CCKAR—schizophrenia	0.00394	0.00472	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—NTS—schizophrenia	0.00386	0.00463	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—ADORA2A—schizophrenia	0.00382	0.00458	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—schizophrenia	0.00377	0.00452	CbGpPWpGaD
Antazoline—Dextropropoxyphene—CYP2D6—schizophrenia	0.00371	0.0223	CrCbGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—schizophrenia	0.0037	0.00444	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—GRM3—schizophrenia	0.00363	0.00436	CbGpPWpGaD
Antazoline—HRH1—IL-4 Signaling Pathway—EP300—schizophrenia	0.00363	0.00436	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HTR6—schizophrenia	0.00357	0.00428	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCK—schizophrenia	0.00352	0.00422	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—schizophrenia	0.00344	0.00413	CbGpPWpGaD
Antazoline—Diphenhydramine—CYP1A2—schizophrenia	0.00337	0.0203	CrCbGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	0.00337	0.00404	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—schizophrenia	0.00331	0.00397	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	0.00327	0.00392	CbGpPWpGaD
Antazoline—Methadone—CYP1A2—schizophrenia	0.00326	0.0196	CrCbGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—schizophrenia	0.0032	0.00383	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—schizophrenia	0.0032	0.00383	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CHRM1—schizophrenia	0.00315	0.00378	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—schizophrenia	0.0031	0.00371	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	0.00305	0.00366	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DGKI—schizophrenia	0.00302	0.00362	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—schizophrenia	0.00301	0.00361	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	0.00295	0.00353	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	0.00295	0.00353	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—GRM5—schizophrenia	0.00293	0.00351	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	0.00287	0.00344	CbGpPWpGaD
Antazoline—Bepridil—ABCB1—schizophrenia	0.00285	0.0171	CrCbGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	0.00284	0.0034	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	0.0028	0.00336	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	0.0028	0.00336	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	0.00279	0.00335	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DGKI—schizophrenia	0.00274	0.00329	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	0.00274	0.00329	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	0.00274	0.00329	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCK—schizophrenia	0.00268	0.00321	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	0.00265	0.00318	CbGpPWpGaD
Antazoline—Fentanyl—ABCB1—schizophrenia	0.00262	0.0158	CrCbGaD
Antazoline—Diphenhydramine—CYP2D6—schizophrenia	0.0026	0.0157	CrCbGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	0.00258	0.00309	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCKAR—schizophrenia	0.00257	0.00308	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—HTR2A—schizophrenia	0.00254	0.00304	CbGpPWpGaD
Antazoline—Methadone—CYP2D6—schizophrenia	0.00251	0.0151	CrCbGaD
Antazoline—HRH1—Signaling by GPCR—PPP1R1B—schizophrenia	0.00251	0.00301	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—ADORA2A—schizophrenia	0.00249	0.00299	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	0.00246	0.00295	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—TAAR6—schizophrenia	0.00241	0.0029	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GRM2—schizophrenia	0.00241	0.0029	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	0.0024	0.00288	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	0.0024	0.00288	CbGpPWpGaD
Antazoline—Phenytoin—ABCB1—schizophrenia	0.00237	0.0143	CrCbGaD
Antazoline—HRH1—Signaling by GPCR—FZD3—schizophrenia	0.00233	0.0028	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—NPY—schizophrenia	0.00233	0.00279	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—schizophrenia	0.00227	0.00272	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HTR1B—schizophrenia	0.00224	0.00269	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—OXT—schizophrenia	0.00224	0.00269	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—NGEF—schizophrenia	0.00223	0.00268	CbGpPWpGaD
Antazoline—HRH1—IL-4 Signaling Pathway—AKT1—schizophrenia	0.00219	0.00263	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PPP3CC—schizophrenia	0.00219	0.00263	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GRM2—schizophrenia	0.00219	0.00263	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—TAAR6—schizophrenia	0.00219	0.00263	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—NTS—schizophrenia	0.00218	0.00262	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HTR1A—schizophrenia	0.00216	0.00259	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—NPS—schizophrenia	0.00213	0.00255	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HTR2C—schizophrenia	0.00209	0.0025	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—DRD1—schizophrenia	0.00209	0.0025	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—RGS4—schizophrenia	0.00205	0.00246	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GRM3—schizophrenia	0.00205	0.00246	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NGEF—schizophrenia	0.00203	0.00243	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—DRD3—schizophrenia	0.00202	0.00242	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR6—schizophrenia	0.00202	0.00242	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NTS—schizophrenia	0.00198	0.00238	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	0.00196	0.00235	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—DRD4—schizophrenia	0.00196	0.00235	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CNR1—schizophrenia	0.00187	0.00225	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—RGS4—schizophrenia	0.00186	0.00224	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GRM3—schizophrenia	0.00186	0.00224	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR6—schizophrenia	0.00183	0.00219	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HTR7—schizophrenia	0.00183	0.00219	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—DRD2—schizophrenia	0.00183	0.00219	CbGpPWpGaD
Antazoline—Methadone—ABCB1—schizophrenia	0.00179	0.0108	CrCbGaD
Antazoline—HRH1—GPCR downstream signaling—CHRM1—schizophrenia	0.00178	0.00213	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—IL3RA—schizophrenia	0.00173	0.00208	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.00168	0.00202	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GRM5—schizophrenia	0.00165	0.00198	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DGKI—schizophrenia	0.00162	0.00194	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CHRM1—schizophrenia	0.00162	0.00194	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL3RA—schizophrenia	0.00158	0.00189	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCK—schizophrenia	0.00151	0.00181	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GRM5—schizophrenia	0.0015	0.0018	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PPP1R1B—schizophrenia	0.00148	0.00178	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PDE4B—schizophrenia	0.00148	0.00177	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCKAR—schizophrenia	0.00145	0.00174	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADORA2A—schizophrenia	0.00141	0.00169	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FZD3—schizophrenia	0.00138	0.00165	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCK—schizophrenia	0.00137	0.00165	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PDE4B—schizophrenia	0.00134	0.00161	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCKAR—schizophrenia	0.00132	0.00158	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—NPY—schizophrenia	0.00131	0.00158	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FES—schizophrenia	0.0013	0.00155	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TAAR6—schizophrenia	0.0013	0.00155	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PPP3CC—schizophrenia	0.0013	0.00155	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GRM2—schizophrenia	0.0013	0.00155	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—HTR2A—schizophrenia	0.00128	0.00153	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADORA2A—schizophrenia	0.00128	0.00153	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR1B—schizophrenia	0.00127	0.00152	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—OXT—schizophrenia	0.00127	0.00152	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR1A—schizophrenia	0.00122	0.00146	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—NPS—schizophrenia	0.0012	0.00144	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NGEF—schizophrenia	0.0012	0.00144	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NPY—schizophrenia	0.00119	0.00143	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR2C—schizophrenia	0.00118	0.00141	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DRD1—schizophrenia	0.00118	0.00141	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NTS—schizophrenia	0.00117	0.0014	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR1B—schizophrenia	0.00115	0.00138	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—OXT—schizophrenia	0.00115	0.00138	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DRD3—schizophrenia	0.00114	0.00137	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR1A—schizophrenia	0.00111	0.00133	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DRD4—schizophrenia	0.00111	0.00133	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RGS4—schizophrenia	0.0011	0.00132	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RTN4—schizophrenia	0.0011	0.00132	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GRM3—schizophrenia	0.0011	0.00132	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NPS—schizophrenia	0.00109	0.00131	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR6—schizophrenia	0.00108	0.0013	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR2C—schizophrenia	0.00107	0.00128	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD1—schizophrenia	0.00107	0.00128	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CNR1—schizophrenia	0.00106	0.00127	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MAG—schizophrenia	0.00104	0.00125	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD3—schizophrenia	0.00104	0.00124	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR7—schizophrenia	0.00103	0.00124	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DRD2—schizophrenia	0.00103	0.00124	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD4—schizophrenia	0.00101	0.00121	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CNR1—schizophrenia	0.000961	0.00115	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CHRM1—schizophrenia	0.000955	0.00115	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD2—schizophrenia	0.000938	0.00112	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR7—schizophrenia	0.000938	0.00112	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL3RA—schizophrenia	0.000931	0.00112	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NRG3—schizophrenia	0.000908	0.00109	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TLE1—schizophrenia	0.000908	0.00109	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GFAP—schizophrenia	0.000898	0.00108	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GRM5—schizophrenia	0.000888	0.00106	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TLE3—schizophrenia	0.00086	0.00103	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCK—schizophrenia	0.000812	0.000974	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PDE4B—schizophrenia	0.000791	0.000949	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCKAR—schizophrenia	0.000778	0.000933	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADORA2A—schizophrenia	0.000755	0.000905	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PLA2G4A—schizophrenia	0.000742	0.00089	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FGA—schizophrenia	0.000724	0.000868	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR2A—schizophrenia	0.000723	0.000867	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NOTCH4—schizophrenia	0.000705	0.000846	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ATP2A2—schizophrenia	0.000705	0.000846	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPY—schizophrenia	0.000705	0.000846	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—OXT—schizophrenia	0.00068	0.000816	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR1B—schizophrenia	0.00068	0.000816	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR2A—schizophrenia	0.000657	0.000788	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR1A—schizophrenia	0.000655	0.000785	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPS—schizophrenia	0.000645	0.000773	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD1—schizophrenia	0.000633	0.000759	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR2C—schizophrenia	0.000633	0.000759	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NTRK2—schizophrenia	0.000615	0.000738	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD3—schizophrenia	0.000613	0.000735	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD4—schizophrenia	0.000595	0.000713	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CNR1—schizophrenia	0.000568	0.000681	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD2—schizophrenia	0.000554	0.000664	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR7—schizophrenia	0.000554	0.000664	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRL—schizophrenia	0.000523	0.000627	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—S100B—schizophrenia	0.000488	0.000585	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ERBB4—schizophrenia	0.000466	0.000559	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PLA2G4A—schizophrenia	0.000438	0.000526	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NRG1—schizophrenia	0.00043	0.000516	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MEF2C—schizophrenia	0.000427	0.000511	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—YWHAZ—schizophrenia	0.000412	0.000494	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ERBB3—schizophrenia	0.000403	0.000483	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR2A—schizophrenia	0.000388	0.000465	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOE—schizophrenia	0.000361	0.000433	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOA1—schizophrenia	0.000357	0.000428	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ESR1—schizophrenia	0.000344	0.000413	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GSK3B—schizophrenia	0.000312	0.000375	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AKT1—schizophrenia	0.000232	0.000278	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AKT1—schizophrenia	0.00021	0.000252	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EP300—schizophrenia	0.000206	0.000247	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TP53—schizophrenia	0.000147	0.000176	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AKT1—schizophrenia	0.000124	0.000149	CbGpPWpGaD
